Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to -$890536.0.

  • Cumberland Pharmaceuticals' Net Cash Flow fell 79406.12% to -$890536.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.3 million, marking a year-over-year decrease of 11740.65%. This contributed to the annual value of -$357440.0 for FY2024, which is 7511.46% up from last year.
  • As of Q3 2025, Cumberland Pharmaceuticals' Net Cash Flow stood at -$890536.0, which was down 79406.12% from $978868.0 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Net Cash Flow's 5-year high stood at $1.9 million during Q2 2023, with a 5-year trough of -$9.8 million in Q1 2022.
  • Moreover, its 5-year median value for Net Cash Flow was $216432.0 (2022), whereas its average is -$503002.7.
  • Within the past 5 years, the most significant YoY rise in Cumberland Pharmaceuticals' Net Cash Flow was 66690.44% (2022), while the steepest drop was 587903.91% (2022).
  • Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Net Cash Flow stood at $1.2 million in 2021, then crashed by 81.93% to $216432.0 in 2022, then crashed by 186.1% to -$186341.0 in 2023, then skyrocketed by 368.02% to $499430.0 in 2024, then crashed by 278.31% to -$890536.0 in 2025.
  • Its Net Cash Flow stands at -$890536.0 for Q3 2025, versus $978868.0 for Q2 2025 and -$2.9 million for Q1 2025.